Antje Augstein

Dresden, SN, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 37 publications

Targeting Mitochondrial Dysfunction With Elamipretide (SS-31) Improves Skeletal Muscle Performance in a HFpEF Rat Model.

Targeting Mitochondrial Dysfunction With Elamipretide (SS-31) Improves Skeletal Muscle Performance in a HFpEF Rat Model.

Journal: Circulation. Heart failure

Published: June 15, 2026

Mitochondrial Targeting by Elamipretide Improves Myocardial Bioenergetics Without Translating into Functional Benefits in HFpEF.

Mitochondrial Targeting by Elamipretide Improves Myocardial Bioenergetics Without Translating into Functional Benefits in HFpEF.

Journal: International journal of molecular sciences

Published: December 17, 2025

Ephrin-A1/EphA2 modulates vascular smooth muscle cell proliferation in vitro, while VSMC-specific ephrin-A1 deletion is not sufficient to alter arteriosclerosis in vivo.

Ephrin-A1/EphA2 modulates vascular smooth muscle cell proliferation in vitro, while VSMC-specific ephrin-A1 deletion is not sufficient to alter arteriosclerosis in vivo.

Journal: Biochimica et biophysica acta. Molecular cell research

Published: July 10, 2025

ZSF1 lean rats - How healthy are they?

ZSF1 lean rats - How healthy are they?

Journal: Animal models and experimental medicine

Published: May 28, 2025

MyoMed205 Counteracts Titin Hyperphosphorylation and the Expression of Contraction-Regulating Proteins in a Rat Model of HFpEF.

MyoMed205 Counteracts Titin Hyperphosphorylation and the Expression of Contraction-Regulating Proteins in a Rat Model of HFpEF.

Journal: Journal of cachexia, sarcopenia and muscle

Published: January 21, 2025

Empagliflozin Improves Diastolic Function in HFpEF by Restabilizing the Mitochondrial Respiratory Chain.

Empagliflozin Improves Diastolic Function in HFpEF by Restabilizing the Mitochondrial Respiratory Chain.

Journal: Circulation. Heart failure

Published: June 07, 2024

Modulation of Titin and Contraction-Regulating Proteins in a Rat Model of Heart Failure with Preserved Ejection Fraction: Limb vs. Diaphragmatic Muscle.

Modulation of Titin and Contraction-Regulating Proteins in a Rat Model of Heart Failure with Preserved Ejection Fraction: Limb vs. Diaphragmatic Muscle.

Journal: International journal of molecular sciences

Published: May 24, 2024

Lean ZSF1 rats in basic research on heart failure with preserved ejection fraction.

Lean ZSF1 rats in basic research on heart failure with preserved ejection fraction.

Journal: ESC heart failure

Published: April 30, 2024

Leucine Supplementation Prevents the Development of Skeletal Muscle Dysfunction in a Rat Model of HFpEF.

Leucine Supplementation Prevents the Development of Skeletal Muscle Dysfunction in a Rat Model of HFpEF.

Journal: Cells

Published: January 08, 2024

Leucine Supplementation Improves Diastolic Function in HFpEF by HDAC4 Inhibition.

Leucine Supplementation Improves Diastolic Function in HFpEF by HDAC4 Inhibition.

Journal: Cells

Published: September 20, 2023

Impact of Different Training Modalities on Molecular Alterations in Skeletal Muscle of Patients With Heart Failure With Preserved Ejection Fraction: A Substudy of the OptimEx Trial.

Impact of Different Training Modalities on Molecular Alterations in Skeletal Muscle of Patients With Heart Failure With Preserved Ejection Fraction: A Substudy of the OptimEx Trial.

Journal: Circulation. Heart failure

Published: October 06, 2022

Empagliflozin Preserves Skeletal Muscle Function in a HFpEF Rat Model.

Empagliflozin Preserves Skeletal Muscle Function in a HFpEF Rat Model.

Journal: International journal of molecular sciences

Published: August 08, 2022

Showing 1-12 of 37

Last Updated: 09/26/2026